These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35508682)

  • 1. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping.
    Xiao Y; Xu G; Cloyd JM; Du S; Mao Y; Pawlik TM
    J Gastrointest Surg; 2022 Aug; 26(8):1670-1678. PubMed ID: 35508682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors.
    Zhou H; Chen Q; Tan W; Qiu Z; Li S; Song Y; Gao S
    Gene; 2017 Aug; 625():72-77. PubMed ID: 28479381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
    Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
    Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening key candidate genes and pathways involved in insulinoma by microarray analysis.
    Zhou W; Gong L; Li X; Wan Y; Wang X; Li H; Jiang B
    Medicine (Baltimore); 2018 Jun; 97(22):e10826. PubMed ID: 29851790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
    Yang ZQ; Liu YJ; Zhou XL
    Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer.
    Liu BX; Huang GJ; Cheng HB
    J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis.
    Wang Q; Yu C
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools.
    Zhang X; Wang Z; Hu L; Shen X; Liu C
    Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of transcription profiling of solid pseudopapillary neoplasm of the pancreas.
    Zhang Y; Han X; Wu H; Zhou Y
    Mol Med Rep; 2017 Aug; 16(2):1635-1642. PubMed ID: 28627654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
    Liu J; Li J; Li H; Li A; Liu B; Han L
    Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.